In our GBM mouse models, elevated SOX2 expression enhances HCMV’s oncomodulatory effects, suggesting that combinatorial expression profiling of IE1 and SOX2 may have prognostic value in patients with gliomas. The gene discussed is SOX2; the disease is glioma.